Filter posts

BIO 2019 Wraps Up in Philadelphia

“The world is beginning to grasp that we’ve entered the dawn of a golden age …

#BIO2019: The State of the Vaccine Industry: Stimulating Sustainable Growth

There’s little doubt that vaccines are one of the most important medical advances ever created. …

#BIO2019: Taking the Pulse of Dealmakers: 2019 Outlook

After a multi-year expansion of company formation and in biopharma valuations, 2018 was a year …

Greenwood : In Drug Pricing Debate, Politicians and Patients Are Not Talking About Same Price

Summary: BIO CEO Jim Greenwood gave the following keynote address at the BIO 2019 International …

It Starts With One: Christopher Marshall and Biotechnology in Early Philadelphia

Christopher Marshall was a busy man. Born in Dublin, Ireland in 1709, Marshall studied in …

Welcome to #BIO2019

As BIO’s President and CEO, who proudly represented the Philadelphia suburbs in Congress for 12 …

It Starts with One…Newborn Screening

Newborn screening is recognized as an essential, preventive public health program for early identification of …

It Starts With One Drop

Despite fifty years of research attempting to develop a solution for a popular health issue, …

Learning from Game Theory to Improve Negotiations Skills

Most new medicines are developed through a process of collaborative licensing agreements or acquisition. Significant …

Starting from One Idea to Building a Winning Company: How to Communicate Value to Investors and Par...

It’s not enough to be a great scientist or entrepreneur with a great idea.  Investors …